GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » Common Stock

EirGenix (ROCO:6589) Common Stock : NT$3,062 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is EirGenix Common Stock?

EirGenix's quarterly common stock increased from Dec. 2023 (NT$3,061 Mil) to Mar. 2024 (NT$3,062 Mil) and increased from Mar. 2024 (NT$3,062 Mil) to Jun. 2024 (NT$3,062 Mil).

EirGenix's annual common stock increased from Dec. 2021 (NT$3,004 Mil) to Dec. 2022 (NT$3,043 Mil) and increased from Dec. 2022 (NT$3,043 Mil) to Dec. 2023 (NT$3,061 Mil).


EirGenix Common Stock Historical Data

The historical data trend for EirGenix's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EirGenix Common Stock Chart

EirGenix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,693.04 2,063.75 3,003.85 3,043.36 3,060.52

EirGenix Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,046.67 3,049.00 3,060.52 3,061.61 3,061.99

EirGenix Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


EirGenix Business Description

Traded in Other Exchanges
N/A
Address
No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in biosimilar and new drug research and development as well as biopharmaceutical contract development and manufacturing services, including cell line construction platforms, process development platforms, analytical science and protein characterisation, as well as PIC/S facilities to provide clinical trial drug production. Its services include Cell Line Development, Process Development, Analytical Science and Quality Control, cGMP manufacturing-mammalian system, cGMP manufacturing-microbial system, and Antibody Drug Conjugate.

EirGenix Headlines

No Headlines